Implantable celecoxib nanofibers made by electrospinning: fabrication and characterization.

IF 3.9 Nanomedicine (London, England) Pub Date : 2024-04-01 Epub Date: 2024-02-02 DOI:10.2217/nnm-2023-0314
Geng Lu, Chuangzan Yang, Kedi Chu, Yi Zhu, Sa Huang, Juying Zheng, Huanhuan Jia, Xiaofang Li, Junfeng Ban
{"title":"Implantable celecoxib nanofibers made by electrospinning: fabrication and characterization.","authors":"Geng Lu, Chuangzan Yang, Kedi Chu, Yi Zhu, Sa Huang, Juying Zheng, Huanhuan Jia, Xiaofang Li, Junfeng Ban","doi":"10.2217/nnm-2023-0314","DOIUrl":null,"url":null,"abstract":"<p><p><b>Background:</b> Osteoarthritis causes tremendous damage to the joints, reducing the quality of life and imposing significant financial burden. An implantable drug-delivery system can improve the symptomatic manifestations with low doses and frequencies. However, the free drug has short retention in the joint cavity. <b>Materials & methods:</b> This study used electrostatic spinning technology to create an implantable drug-delivery system loaded with celecoxib (celecoxib nanofibers [Cel-NFs]) to improve retention and bioavailability. <b>Results:</b> Cel-NFs exhibited good formability, hydrophilicity and tensile properties. Cel-NFs were able to continuously release drugs for 2 weeks and increase the uptake capacity of Raw 264.7 cells, ultimately ameliorating symptoms in osteoarthritis rats. <b>Conclusion:</b> These results suggest that Cel-NFs can effectively ameliorate cartilage damage, reduce joint pain and alleviate osteoarthritis progression.</p>","PeriodicalId":74240,"journal":{"name":"Nanomedicine (London, England)","volume":" ","pages":"657-669"},"PeriodicalIF":3.9000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nanomedicine (London, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/nnm-2023-0314","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/2/2 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Osteoarthritis causes tremendous damage to the joints, reducing the quality of life and imposing significant financial burden. An implantable drug-delivery system can improve the symptomatic manifestations with low doses and frequencies. However, the free drug has short retention in the joint cavity. Materials & methods: This study used electrostatic spinning technology to create an implantable drug-delivery system loaded with celecoxib (celecoxib nanofibers [Cel-NFs]) to improve retention and bioavailability. Results: Cel-NFs exhibited good formability, hydrophilicity and tensile properties. Cel-NFs were able to continuously release drugs for 2 weeks and increase the uptake capacity of Raw 264.7 cells, ultimately ameliorating symptoms in osteoarthritis rats. Conclusion: These results suggest that Cel-NFs can effectively ameliorate cartilage damage, reduce joint pain and alleviate osteoarthritis progression.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
利用电纺丝技术制造的可植入塞来昔布纳米纤维:制备与表征。
背景:骨关节炎会对关节造成巨大损害,降低生活质量,并带来沉重的经济负担。植入式给药系统能以低剂量和低频率改善症状表现。然而,游离药物在关节腔内的存留时间较短。材料与方法:本研究利用静电纺丝技术创建了一种植入式给药系统,其中装载了塞来昔布(塞来昔布纳米纤维 [Cel-NFs]),以提高药物的保留率和生物利用度。研究结果塞来昔布纳米纤维具有良好的成型性、亲水性和拉伸性。Cel-NFs 能够持续释放药物 2 周,并能提高 Raw 264.7 细胞的吸收能力,最终改善骨关节炎大鼠的症状。结论这些结果表明,Cel-NFs 能有效改善软骨损伤、减轻关节疼痛并缓解骨关节炎的进展。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
PLGA/PVA nanoparticles to deliver a protein-based cancer vaccine targeting GPC1 for the treatment of pancreatic ductal adenocarcinoma. Sodium alginate functionalized biocompatible selenium nanocarriers loaded trans-resveratrol for mitochondrial targeted HepG2 hepatocellular carcinoma inhibition study. Extracellular vesicles targeting EGFR inhibit MAOA expression and activity by delivering curcumin for the treatment of asthma. Advances in Prussian blue nanoparticle-based anticancer platforms: synthesis, functionalization, and therapeutic applications. The role of chitosan-based nano systems in emerging vaccine technologies: current status and future expectations.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1